title: Breakthrough fungemia caused by azole-resistant Candida albicans in neutropenic patients with acute leukemia.
authors.affiliation: Department of Oral Surgery, Hiroshima Red Cross Atomic Bomb Survivors Hospital, Hiroshima, Japan. myoken@do5.enjoy.ne.jp
authors.forename: Yoshinari
authors.initials: Y
authors.lastname: Myoken
authors.forename: Tai-Ichi
authors.initials: T
authors.lastname: Kyo
authors.forename: Tadahiro
authors.initials: T
authors.lastname: Kohara
authors.forename: Megumu
authors.initials: M
authors.lastname: Fujihara
authors.forename: Tatsumi
authors.initials: T
authors.lastname: Sugata
authors.forename: Yuzuru
authors.initials: Y
authors.lastname: Mikami
mesh_terms: D000208:Acute Disease; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000666:Amphotericin B / Q000627:therapeutic use; D000935:Antifungal Agents / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000009:adverse effects / Q000627:therapeutic use; D002176:Candida albicans / Q000187:drug effects; D002177:Candidiasis / Q000188:drug therapy*; D018890:Chemoprevention; D004352:Drug Resistance, Microbial; D005260:Female; D015725:Fluconazole / Q000627:therapeutic use; D016469:Fungemia / Q000188:drug therapy*; D006801:Humans; D007938:Leukemia / Q000150:complications / Q000188:drug therapy; D008297:Male; D008826:Microbial Sensitivity Tests; D008875:Middle Aged; D009503:Neutropenia / Q000209:etiology
chemical_list: D000935:Antifungal Agents; D000970:Antineoplastic Agents; D000666:Amphotericin B; D015725:Fluconazole